COLAGROSSI, LUNA
 Distribuzione geografica
Continente #
NA - Nord America 2.376
AS - Asia 843
EU - Europa 647
SA - Sud America 187
AF - Africa 31
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.089
Nazione #
US - Stati Uniti d'America 2.332
SG - Singapore 346
IT - Italia 218
BR - Brasile 151
CN - Cina 126
RU - Federazione Russa 110
HK - Hong Kong 82
BD - Bangladesh 76
VN - Vietnam 75
DE - Germania 59
IE - Irlanda 57
KR - Corea 48
FI - Finlandia 41
FR - Francia 36
JP - Giappone 33
GB - Regno Unito 32
CA - Canada 22
SE - Svezia 18
IN - India 15
MX - Messico 15
NL - Olanda 15
ZA - Sudafrica 14
AR - Argentina 13
PL - Polonia 13
CZ - Repubblica Ceca 10
ID - Indonesia 10
UA - Ucraina 10
TR - Turchia 9
AT - Austria 8
ES - Italia 8
PY - Paraguay 7
CO - Colombia 5
AU - Australia 4
KE - Kenya 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
IQ - Iraq 3
PE - Perù 3
PH - Filippine 3
PK - Pakistan 3
TZ - Tanzania 3
CH - Svizzera 2
GR - Grecia 2
MA - Marocco 2
RS - Serbia 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BB - Barbados 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
CM - Camerun 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GH - Ghana 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
NG - Nigeria 1
NI - Nicaragua 1
PR - Porto Rico 1
RO - Romania 1
SV - El Salvador 1
TD - Ciad 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.089
Città #
Wilmington 477
Houston 346
Singapore 187
Woodbridge 132
Ashburn 113
San Jose 108
Fairfield 98
Chandler 92
Hong Kong 80
Beijing 71
Council Bluffs 70
New York 66
Rome 60
The Dalles 49
Dallas 48
Dublin 44
Los Angeles 40
Seattle 37
Santa Clara 35
Tokyo 32
Cambridge 29
Munich 28
Helsinki 26
Ho Chi Minh City 26
Milan 26
Ann Arbor 25
Medford 24
Dearborn 18
Moscow 18
Buffalo 17
Denver 15
Hanoi 15
São Paulo 13
London 12
Johannesburg 11
Lappeenranta 11
Lauterbourg 11
Lawrence 11
Engelhard 10
Frankfurt am Main 10
Nuremberg 10
Warsaw 10
Chicago 9
Menlo Park 8
San Diego 8
Boston 7
Montreal 7
North Bergen 7
Stockholm 7
Atlanta 6
Creede 6
Jakarta 6
Olomouc 6
Orem 6
Poplar 6
Querétaro 6
Redondo Beach 6
St. George 6
Toronto 6
Cedarhurst 5
Chennai 5
Colorado Springs 5
Fortaleza 5
Hải Dương 5
Modena 5
Nepi 5
Rio de Janeiro 5
San Francisco 5
Albano Laziale 4
Brno 4
Manchester 4
Phoenix 4
Amsterdam 3
Ankara 3
Asunción 3
Biên Hòa 3
Boardman 3
Bologna 3
Brooklyn 3
Dar es Salaam 3
Florence 3
Guangzhou 3
Guarulhos 3
Istanbul 3
Jacksonville 3
Manaus 3
Mexico City 3
Miami 3
Minneapolis 3
Monte Vista 3
Nairobi 3
Naples 3
Nova Iguaçu 3
Palazzolo sull'Oglio 3
Piscataway 3
Salvador 3
Antakya 2
Bogotá 2
Boise 2
Bollate 2
Totale 2.815
Nome #
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal 452
High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance 381
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 333
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 265
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe 259
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection 253
CMV seroprevalence and coronary CMV-DNA detection in immunocompetent patients with heart diseases 138
Pre-vaccination immune markers predict response to BNT162b2 mRNA vaccine in vulnerable groups – The CONVERS project, report from a pediatric tertiary hospital 123
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed? 118
Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis B 117
SARS-CoV-2 genomic surveillance and reliability of PCR single point mutation assay (SNPsig® SARS-CoV-2 EscapePLEX CE) for the rapid detection of variants of concern in Cameroon 115
Managing low-level HIV viraemia in antiretroviral therapy: a systematic review and meta-analysis 112
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 102
Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies 99
Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of Treatment 98
Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome 97
Management of low-level HIV viremia during antiretroviral therapy: Delphi consensus statement and appraisal of the evidence 95
Highly specific memory b cells generation after the 2nd dose of bnt162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal iga 95
Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens 94
Presence and Significance of Multiple Respiratory Viral Infections in Children Admitted to a Tertiary Pediatric Hospital in Italy 90
An increase in the levels of middle surface antigen characterizes patients developing HBV-driven liver cancer despite prolonged virological suppression 89
A new epidemic wave of Bordetella pertussis in paediatric population: impact and role of co-infections in pertussis disease 88
Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity 86
Parvovirus B19 Rebound 85
Safety of Nirmatrelvir-Ritonavir Administration in Children With Immunodeficiency and/or Comorbidities With SARS-CoV-2 Infection A Retrospective Clinical Report 85
Influenza viruses circulation in a tertiary care children hospital in Rome: a comparison between 2022 and the previous 5 years 73
Whooping Cough Cases Increase in Central Italy after COVID-19 Pandemic 63
Assessing the utilization of HIV genotype resistance testing: Insight from Italian Infectious Diseases Units 63
Humoral and cellular immunogenicity and safety up to 4 months after vaccination with BNT162B2 mRNA COVID-19 vaccine in heart and lung transplanted young adults 53
Diagnostic Concordance of Two- and Three-Gene SARS-CoV-2 Molecular Assays in Cameroon: Implications for Efficient Pandemic Response in Low- and Middle-Income Countries 52
Viral dynamics and factors associated with duration of COVID-19 positivity: evidence from the first-three epidemiological waves in Cameroon 21
Whole-Genome Sequencing of Adenovirus Genotypes and Clinical Implications in Pediatric Patients 10
Viral Burden of Respiratory Syncytial Virus and Viral Coinfections as Factors Regulating Paediatric Disease Severity 9
Totale 4.213
Categoria #
all - tutte 15.581
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.581


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 0 7
2021/2022146 0 8 0 4 20 3 7 1 54 11 6 32
2022/2023300 18 26 18 20 39 45 40 24 27 9 28 6
2023/2024141 10 21 12 4 19 28 13 4 2 11 1 16
2024/2025718 14 105 63 36 21 41 64 60 79 85 71 79
2025/20261.644 136 89 193 147 144 70 167 177 133 154 162 72
Totale 4.213